France · Delayed Price · Currency is EUR Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of EUR 97.67 billion. The enterprise value is 110.65 billion.
| Market Cap | 97.67B |
| Enterprise Value | 110.65B |
Important Dates
The last earnings date was Thursday, January 29, 2026.
| Earnings Date | Jan 29, 2026 |
| Ex-Dividend Date | May 12, 2025 |
Share Statistics
Sanofi has 1.21 billion shares outstanding. The number of shares has decreased by -2.43% in one year.
| Current Share Class | 1.21B |
| Shares Outstanding | 1.21B |
| Shares Change (YoY) | -2.43% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 48.77% |
| Float | 1.09B |
Valuation Ratios
The trailing PE ratio is 20.07 and the forward PE ratio is 9.65. Sanofi's PEG ratio is 1.07.
| PE Ratio | 20.07 |
| Forward PE | 9.65 |
| PS Ratio | 2.09 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 7.78 |
| P/FCF Ratio | 10.87 |
| P/OCF Ratio | 9.09 |
| PEG Ratio | 1.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.68, with an EV/FCF ratio of 12.31.
| EV / Earnings | 14.16 |
| EV / Sales | 2.37 |
| EV / EBITDA | 8.68 |
| EV / EBIT | 11.65 |
| EV / FCF | 12.31 |
Financial Position
The company has a current ratio of 1.09, with a Debt / Equity ratio of 0.28.
| Current Ratio | 1.09 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.58 |
| Debt / FCF | 2.26 |
| Interest Coverage | 18.17 |
Financial Efficiency
Return on equity (ROE) is 6.66% and return on invested capital (ROIC) is 9.35%.
| Return on Equity (ROE) | 6.66% |
| Return on Assets (ROA) | 4.65% |
| Return on Invested Capital (ROIC) | 9.35% |
| Return on Capital Employed (ROCE) | 9.80% |
| Weighted Average Cost of Capital (WACC) | 5.57% |
| Revenue Per Employee | 624,162 |
| Profits Per Employee | 104,388 |
| Employee Count | 74,846 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.32 |
Taxes
In the past 12 months, Sanofi has paid 1.04 billion in taxes.
| Income Tax | 1.04B |
| Effective Tax Rate | 17.33% |
Stock Price Statistics
The stock price has decreased by -22.31% in the last 52 weeks. The beta is 0.37, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -22.31% |
| 50-Day Moving Average | 80.68 |
| 200-Day Moving Average | 83.73 |
| Relative Strength Index (RSI) | 53.45 |
| Average Volume (20 Days) | 2,495,756 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of EUR 46.72 billion and earned 7.81 billion in profits. Earnings per share was 6.37.
| Revenue | 46.72B |
| Gross Profit | 33.79B |
| Operating Income | 9.65B |
| Pretax Income | 6.02B |
| Net Income | 7.81B |
| EBITDA | 12.64B |
| EBIT | 9.65B |
| Earnings Per Share (EPS) | 6.37 |
Balance Sheet
The company has 7.67 billion in cash and 20.33 billion in debt, with a net cash position of -12.66 billion or -10.48 per share.
| Cash & Cash Equivalents | 7.67B |
| Total Debt | 20.33B |
| Net Cash | -12.66B |
| Net Cash Per Share | -10.48 |
| Equity (Book Value) | 71.71B |
| Book Value Per Share | 59.10 |
| Working Capital | 2.61B |
Cash Flow
In the last 12 months, operating cash flow was 10.75 billion and capital expenditures -1.76 billion, giving a free cash flow of 8.99 billion.
| Operating Cash Flow | 10.75B |
| Capital Expenditures | -1.76B |
| Free Cash Flow | 8.99B |
| FCF Per Share | 7.44 |
Margins
Gross margin is 72.34%, with operating and profit margins of 20.66% and 16.72%.
| Gross Margin | 72.34% |
| Operating Margin | 20.66% |
| Pretax Margin | 12.89% |
| Profit Margin | 16.72% |
| EBITDA Margin | 27.05% |
| EBIT Margin | 20.66% |
| FCF Margin | 19.24% |
Dividends & Yields
This stock pays an annual dividend of 4.12, which amounts to a dividend yield of 5.10%.
| Dividend Per Share | 4.12 |
| Dividend Yield | 5.10% |
| Dividend Growth (YoY) | 4.26% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 61.08% |
| Buyback Yield | 2.43% |
| Shareholder Yield | 7.54% |
| Earnings Yield | 8.00% |
| FCF Yield | 9.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |